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BACKGROUND/OBJECTIVES: Bone is a preferred site of breast cancer metastasis, suggesting the presence of
tissue-specific features that attract and promote the outgrowth of breast cancer cells. We sought to identify
parameters of human bone tissue associated with breast cancer cell osteotropism and colonization in the
metastatic niche. METHODS: Migration and colonization patterns of MDA-MB-231-fLuc-EGFP (luciferase-
enhanced green fluorescence protein) and MCF-7-fLuc-EGFP breast cancer cells were studied in co-culture with
cancellous bone tissue fragments isolated from 14 hip arthroplasties. Breast cancer cell migration into tissues and
toward tissue-conditioned medium was measured in Transwell migration chambers using bioluminescence
imaging and analyzed as a function of secreted factors measured by multiplex immunoassay. Patterns of breast
cancer cell colonization were evaluated with fluorescence microscopy and immunohistochemistry. RESULTS:
Enhanced MDA-MB-231-fLuc-EGFP breast cancer cell migration to bone-conditioned versus control medium was
observed in 12/14 specimens (P = .0014) and correlated significantly with increasing levels of the adipokines/
cytokines leptin (P = .006) and IL-1β (P = .001) in univariate and multivariate regression analyses. Fluorescence
microscopy and immunohistochemistry of fragments underscored the extreme adiposity of adult human bone
tissues and revealed extensive breast cancer cell colonization within the marrow adipose tissue compartment.
CONCLUSIONS: Our results show that breast cancer cells migrate to human bone tissue-conditioned medium in
association with increasing levels of leptin and IL-1β, and colonize the bone marrow adipose tissue compartmentHuman Immune Monitoring Shared Resource, Cell Sciences Imaging Shared Resource, and
Biostatistics and Research Informatics Shared Resource.
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850 Breast Cancer Cell Colonization of Bone Templeton et al. Neoplasia Vol. 17, No. 12, 2015of cultured fragments. Bone marrow adipose tissue and its molecular signals may be important but understudied
components of the breast cancer metastatic niche.
Neoplasia (2015) 17, 849–861Introduction
Breast cancer metastasis is responsible for most breast cancer
mortality. The process unfolds when epithelial cells lining the
mammary tree traverse the surrounding basement membrane and
invade the collagenous stroma populated by fibroblasts, adipocytes,
and infiltrating immune cells to access vasculature conveying passage
to distant organs. Although breast cancer commonly spreads to lung,
brain, and liver, the most prevalent site of breast cancer metastasis is
bone [1,2]. This organ-specific metastatic pattern has long been
explained by Paget’s seed and soil hypothesis, which postulates that
the microenvironment of certain organs attracts and promotes the
growth of specific types of cancer cells [3]. Bone-seeking malignancies
include breast and prostate cancers, suggesting the presence of
bone-specific factors that attract and promote colonization of these
but not all metastatic cancers [2]. An alternate explanation, posited by
Ewing, proposes that permissive features of the target organ
microvasculature facilitate specific metastatic patterns [4]. Breast
cancer metastasis to bone occurs most frequently throughout the axial
skeleton, which is populated by “red marrow” where active
hematopoiesis requires continuous passage of cells into the circulation
[5,6]. As such, sinusoids that permit the exit of cells during
hematopoiesis may facilitate the enhanced entry of circulating tumor
cells to colonize the bone marrow. However, not all metastatic cancers
spread to the bone, indicating that access alone may be insufficient.
Thus, although circulatory parameters may facilitate enhanced access
to certain organs, it appears that other properties must be responsible
for migration into and colonization of the metastatic niche.
To date, a number of different isolated bone cell types have been
evaluated for their ability to recruit breast cancer cells, including
osteoblasts; osteoclasts; mesenchymal stem cells; fibroblasts; and,
most recently, adipocytes [7–17]. These studies have implicated
numerous factors in breast cancer cell osteotropism, including SDF-1,
CTACK, RANKL, OPG, OPN, PDGF-AB/BB, VEGF, IL-6, IL-8,
GM-CSF, G-CSF, ENA-78, and 6Ckine [7,9–16]. In addition,
animal model studies of bone-seeking malignancies have revealed
specific areas within the bone microenvironment believed to host
early colonization events [18], leading to the proposal of specific
metastatic niches, including the hematopoietic stem cell niche [19];
the perivascular niche [20]; and, most recently, the osteogenic niche
[21]. However, although the role of the microenvironment in cancer
progression is widely acknowledged [22–24], a potentially important
breast cancer metastatic niche within the bone has been understudied.
The mature human skeleton, which is a frequent target of breast
cancer metastasis, becomes increasingly populated by adipose tissue
with age [25–27]. Although recent studies have revealed a central role
for bone marrow adipose tissue in prostate cancer progression [28],
relatively little attention has been paid to the potential role of bone
marrow adipose tissue in breast cancer cell osteotropism and
colonization events. We previously established a human bone tissue
co-culture model for studying breast cancer cell behavior within thenative three-dimensional microenvironment of the aging human skeleton
[29,30]. In this study, we sought to identify parameters of the human bone
tissue microenvironment associated with breast cancer cell migration and
colonization events. Our observations underscore the extreme adiposity of
the mature human skeleton and reveal robust breast cancer cell infiltration
of the bone marrow adipose tissue compartment.
Methods
Human Femur Tissue
Femoral heads were collected from 14 patients undergoing elective
total hip replacement (THR) in the Department of Orthopaedic
Surgery at the Stanford University Medical Center over a period of 6
months. Specimens were collected from 8 female and 6 male patients
ranging from 42 to 89 years of age (average = 63; median = 59). All
tissues were collected as deidentified specimens in accordance with
regulations of the Stanford University Research Compliance Office.
Per HIPAA regulations, the exact age of the one specimen in our
study isolated from an individual over the age of 89 was unknown but
was estimated as 89 years for statistical calculations. Discarded femoral
head specimens were placed in physiological saline, transported to the
laboratory immediately following surgery, and placed into a Pyrex dish
(VWR, Radnor, PA). Using a sterile glove to hold the femoral head with
one hand, cancellous bone fragments measuring ~3 to 5 mm2 were
dissected from the shaft using a surgical Rongeur (Fine Science Tools,
Foster City, CA) for placement into migration chambers and culture
dishes as described previously [29,30].
Breast Cancer Cell Lines
MDA-MB-231, MCF-7, and SKBR3 breast cancer cell lines and
MCF-10A breast cells were purchased from the American Type
Culture Collection (Rockville, MD) and engineered for the stable
expression of firefly luciferase with the Sleeping Beauty transposon
plasmid pKT2/LuBiG and the transposase plasmid pK/hUbiC-SB11
[31,32]. The resulting transfected cell lines are referred to as
MDA-MB-231-fLuc-EGFP, MCF-7-fLuc-EGFP, SKBR3-fLuc-
EGFP, and MCF-10A-fLuc-EGFP. All cell lines tested negative for
mycoplasma using the MycoAlert Mycoplasma Detection Kit (Lonza,
Rockland, ME).
Direct Seeding of Breast Cancer Cells onto Bone Tissue
Fragments to Image Colonization Patterns by Fluorescence and
Confocal Microscopy
Bone fragments measuring ~3 mm in diameter were placed into
the empty wells of a 24-well tissue culture plate (1 fragment/well).
Cell suspensions delivering 1 × 103 to 1 × 106 MDA-MB-231-
fLuc-EGFP or MCF-7-fLuc-EGFP cells in 10-μl volumes of
DMEM-10% FBS were pipetted directly onto the top of each bone
fragment. After all fragments were seeded, the plate was incubated in a
humidified 37°C tissue culture incubator with 5% CO2 for 45
minutes to promote cell attachment. Once cells attached, 1 to 2 ml of
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for culture in a 37°C tissue culture incubator. After 24 hours of
culture, 5 μl of OsteoSense 680 (PerkinElmer) was added to each well
to achieve a concentration of 1.6 nmol/2 ml of culture medium to
label the mineralized trabeculae of the bone fragments, after which
the plates were incubated in a 37°C tissue culture incubator for an
additional 24 hours. For fluorescence microscopy at 48 hours,
fragments were transferred to a 24-well tissue culture plate containing
1 ml of FluoroBrite DMEM (Life Sciences)-10% FBS/well and
imaged with an epifluorescence microscope (EVOS, Life Technol-
ogies) configured to detect EGFP at 488-nm and Osteosense at
680-nm excitation wavelengths, respectively. For confocal microsco-
py, the fragments were incubated in a mixture of 10 ml of FluoroBrite
DMEM-10% FBS and 0.2 ml of Oil Red stock solution (3 mg/ml in
100% isopropanol) for 1 hour and then transferred to FluoroDishes
(World Precision Instruments) containing fresh FluoroBrite
DMEM-10% FBS for imaging on an SP8 confocal microscope
configured to detect EGFP at 488-nm, and Oil Red O and
Osteosense at 680-nm excitation wavelengths, respectively. Z stacks
were acquired at 20× magnification and rendered into 3-dimensional
images using Volocity 3D Image Analysis Software (PerkinElmer).
Culture of Bone Marrow Adipocytes
Bone marrow was isolated from cancellous bone tissues by flushing
individual fragments with 10-ml volumes of PBS expelled from a
syringe fitted with a 25-guage needle and filtering the effluent
through 70-μm strainers seated into 50-ml conical tubes. The
resulting marrow cell suspensions were centrifuged for 3 minutes at
room temperature at 300×g. Pellets were resuspended in ROCK
medium [33] and transferred to 24-well tissue culture plates.
Immunohistochemical Analysis
Bone tissue fragments were fixed in 10% buffered formalin,
decalcified, and processed for paraffin embedding and slide
preparation. Tissue sections were stained with hematoxylin and
eosin or processed for immunohistochemical analysis using a
monoclonal mouse anti-human cytokeratin antibody (Clone AE1/
AE3) (Dako Cytomation, Carpenteria, CA).
Generation of Bone Tissue Culture Supernatants for Migration
Assays and Secretome Analysis
Three fragments from each THR specimen were used to generate
bone tissue culture supernatants for use in migration assays and
secretome analysis. Bone tissue fragments were transferred into 3
separate wells of a 12-well tissue culture plate containing 2.2 ml of
DMEM-10% FBS per well. Three control wells received equivalent
volumes of medium but no fragments. Plates were incubated for 24
hours at 37°C. At 24 hours, the medium was removed and
replenished for all tissue-containing and control wells, followed by
an additional 24 hours of incubation. At 48 hours, 0.9- and 1-ml
aliquots of medium were collected from all wells for use in migration
and secretome analyses respectively.
Migration Assays
Transwell permeable cell culture inserts with 8-μm pores (Corning
Incorporated Life Sciences, Tewksbury, MA) were used for two
different types of migration assays [30]. In the first type of assay, using
a nontraditional “reverse” migration protocol illustrated in Figure 3A,
the cell culture inserts were placed upside down to be seeded withbreast cancer cell suspensions (1 × 105 luciferase-positive breast
cancer cells per 50 μl) onto the bottom surfaces of the insert cups.
The seeded cups were incubated at 37°C, 5% CO2 for 45 minutes to
promote cell attachment, after which they were turned right side up
for placement into the wells of a 24-well tissue culture plate
(MULTIWELL, Becton Dickinson, Franklin Lakes, NJ) containing
0.9 ml DMEM-10% FBS/well. Single bone tissue fragments
measuring ~3 mm in diameter or control glass beads were placed
into individual seeded inserts, which were then submerged in 450 μl
of DMEM-10% FBS/well. Migration plates were incubated at 37°C,
5% CO2 for 24 h, after which the bone fragments and control glass
beads were transferred into DMEM-10% FBS–containing wells of a
fresh 24-well tissue culture plate to assess the presence of
bioluminescence signal (Figure 3, B and C). In the second type of
assay (using a traditional protocol) diagrammed in Figure 4A, 350 μl
of DMEM-10% FBS containing 1 × 105 luciferase-positive breast
cancer cells were seeded onto the upper surfaces of insert cups seated
in an empty standard 24-well tissue culture plate and then incubated
at 37°C, 5% CO2 for 45 minutes to promote cell attachment. Seeded
inserts were then transferred to a MULTIWELL 24-well tissue
culture plate containing 0.9 ml of THR supernatant or control
DMEM-10% FBS medium per well. Migration plates were incubated
at 37°C, 5% CO2 for 20 hours, after which the inserts were removed
from all wells (Figure 4B). Once the inserts were removed, the
receiver plate was imaged with an IVIS imaging system (Xenogen
Product of Perkin Elmer, Waltham, MA) to detect cells that migrated
and attached to the bottom of each well (Figure 4C). Each
experimental sample (bone supernatants or fragments from a given
THR specimen, or control medium) was tested in triplicate.
Bioluminescence Imaging
Bioluminescence imaging (BLI) was performed on cells and tissues
following migration experiments in an IVIS 50 Imaging Platform
(Xenogen Product of Perkin Elmer, Waltham, MA) immediately
following addition of D-luciferin substrate (150 μg/ml) to all wells.
Imaging parameters were F-stop of 1, small binning, level D, and
exposure time of 30 seconds. The signal intensities are reported
as average radiance (photons/s per cm2 per sr). Average radiance
was integrated over individual wells designated as regions of
interest using the Living Image Software Program (Version 4.3.1.
Perkin Elmer).
Statistical Analysis of Breast Cancer Cell Migration to Bone
Fragments versus Glass Beads, and Bone-Conditioned versus
Control Medium
The migration of MDA-MB-231-fLuc-EGFP cells to triplicate sets
of wells containing bone tissue fragments versus control glass beads
was evaluated across 14 THR specimens by measuring the presence
versus absence of bioluminescence signal in each well. Comparison of
the numbers of signals in wells with bone fragments versus glass beads
was analyzed using a two-sided Fisher’s exact test. The migration of
MDA-MB-231-fLuc-EGFP cells to triplicate wells containing bone
tissue supernatant versus control medium was quantified across 14
THR specimens using BLI and expressed as average radiance
(photons/s per cm2 per sr). For the purpose of statistical analysis,
the average radiance values were transformed by taking natural
logarithms. We tested the null hypothesis that the mean log-
transformed radiance values do not differ between the averaged
bone-conditioned supernatant and control medium wells using the
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one-way analysis of variance applied to replicated data.
Bone Tissue Fragment Secretome Analysis
Multiplex immunoassays of 75 protein analytes including
cytokines, growth factors, and adipokines were performed on the
cultured bone tissue fragment supernatants and control media
generated in triplicate for migration assays performed across 14 of
the THR specimens. One-milliliter volumes of bone tissue
fragment-conditioned medium or DME-10% FBS control medium
from all wells were collected into microfuge tubes and centrifuged for
5 minutes at 13,000 rpm on a tabletop microcentrifuge at room
temperature. Supernatants from these centrifugations were stored at −
80°C until analysis using MILLIPLEX MAP magnetic bead
immunoassay kits (EMD Millipore, Billerica, MA) based on the
Luminex xMAP technology. Levels of analytes were quantitatively
measured using MILLIPLEX MAP Human Cytokine/Chemokine
Panels I and II, Human Bone Panel, and RANKL (EMD Millipore,
Billerica, MA) as per the manufacturer’s instructions. Duplicate
aliquots of each supernatant sample were evaluated for each
biomarker. In brief, 25 μl of supernatant and control samples (or
standards) was incubated with 25 μl of magnetic beads conjugated
with capture antibodies in a 96-well plate overnight at 4°C. On day 2,
the beads were washed, 25 or 50 μl biotinylated detection antibody
cocktail was added, and the assay plates were incubated at room
temperature for 1 hour. Then, 25 μl of streptavidin-phycoerythrin
was added for a further 30-minute incubation. The beads were then
washed and resuspended in 100 μl buffer to read fluorescence levels
on a Luminex 200 Instrument. Fluorescence levels generated in the
sample data set were expressed as median fluorescence intensity
(MFI). MFI data were used for subsequent analyses based on two
considerations: 1) our choice of bone tissue culture supernatant
volumes was arbitrary, and 2) matrix effects result in an
approximation of concentration [34]. The standard curves offer a
semiquantitative normalization method. Because our intent was to
determine the association between migration and analyte levels, we
employed the raw MFI data [35].
Statistical Analysis of Migration as a Function of
Biomarker Levels
To evaluate MDA-MB-231-fLuc-EGFP breast cancer cell migra-
tion to bone tissue supernatants as a function of analyte levels, BLI
signal (reflecting migration) was analyzed as a function of MFI signal
(reflecting analyte concentration) across triplicate samples from 13
THR specimens (THRs 44-56) by regression analysis using linear
mixed models. (THR 43 supernatants were used for pilot
immunoassay protocol development and thus were not included in
statistical analyses.) More specifically, the ratios (fold increase) of BLI
signals detected in migration assays for conditioned versus control
medium were analyzed as a function of the ratios of MFI signal for
analytes in the same samples. Log-transformed values were used for all
statistical tests. R (R Core Team, 2012) and the software tool lme4
package in R v3.1.2 were used to perform a linear mixed effects
analysis of the relationship between BLI and analyte MFI ratios
[36,37]. We entered analyte MFI ratios and plate IDs (to account for
batch effects) into the model as fixed effects and intercepts for patients
as random effects. Univariate regression analysis [with and without
adjustment for age, gender, and false discovery rate (FDR) (q = 0.05)]
was performed on all 75 analytes interrogated by the 4 MILLIPLEXMAP panels. Coefficients and P values for this analysis are listed in
Supplementary Table 1. In addition, multivariate regression analysis
(including age and gender as covariates) was performed to test the
association of five of the analytes interrogated by the MILLIPLEX
MAP Human Bone Panel (leptin, IL-1β, IL-6, OPG, OPN) with
breast cancer cell migration. All P values were two-tailed.
Results
THR Specimens
Fourteen femoral head specimens were collected as discarded
tissues following total hip replacement surgeries performed in the
Department of Orthopaedic Surgery at the Stanford University
School of Medicine over a period of 6 months. Bone specimens were
collected from male and female patients to survey the full spectrum of
properties potentially underlying the progression of bone-seeking
malignancies, which also occur in the male skeleton (e.g., prostate
cancer). All femoral heads included a portion of the proximal femur,
containing cancellous bone tissue (Figure 1A), the color of which
varied from red to yellow across patient specimens, as illustrated by
the fragments shown in Figure 1B. The cancellous tissue fragments,
isolated from individuals ranging from 42 to 89 years of age,
consistently harbored copious amounts of adipose tissue, as revealed
by histology (Figure 1C), fluorescence microscopy (Figure 1D), the
production of fat micelles during explant culture (Figure 1E), and the
robust outgrowth of adipocytes from cultured bone marrow cells
(Figure 1F ). These qualitative observations illustrate the extreme
adiposity of the mature human bone marrow compartment.
Patterns of Breast Cancer Cell Colonization
During 48 hours of co-culture following direct seeding of breast
cancer cells onto tissue fragments, breast cancer cells colonized the
mineralized and marrow compartments of the trabecular bone
fragments. Fluorescence microscopy revealed extensive infiltration of
MDA-MB-231-fLuc-EGFP and MCF-7-fLuc-EGFP cells into the
marrow compartment, where they displayed direct, extensive contact
with adipocytes (Figure 2A). Postculture immunohistochemistry
confirmed the presence of cytokeratin-positive MCF-7-fLuc-EGFP
cells surrounding adipocytes in fixed bone tissues (Figure 2B).
Confocal microscopy further illustrated the extensive, direct contacts
between MCF-7-fLuc-EGFP breast cancer cells and adipocytes in
bone fragments stained with Oil Red, revealing breast cancer cell
psuedopodial extensions around adjacent adipocytes (Figure 2, C
and D; Supplemental Data Video 1). Although our qualitative
observations revealed breast cancer cell contacts with bone cells
throughout the mineralized and marrow compartments, they
exhibited preferential, directed migration toward adipocytes. These
patterns of colonization reveal extensive breast cancer cell infiltration
of the bone marrow adipose tissue compartment and direct contact
between breast cancer cells and adipocytes.
Breast Cancer Cell Line Migration to Bone Tissue Fragments
MDA-MB-231-fLuc-EGFP cells migrated through microporous
membranes to colonize bone fragments as illustrated in Figure 3, A
and B. Colonization following migration was detected with BLI
following transfer of fragments and beads to wells containing fresh
medium, as illustrated in Figure 3C. Migration was significantly
greater to bone tissue fragments (15/42) compared with control glass
beads (3/42) as determined by the Fisher’s exact test (P = .003), with
A B
D
C
E
THR 65
1 mm 1 mm
THR 76THR 63THR 65
F
30 µm3.2 mm
.45 mm
45 µm
130 µm
.9 cm
40X
Figure 1. Adipose tissue is a prominent component of the mature human bone microenvironment and is accessible for study in a tissue
explant model. (A) Femoral head removed during total hip replacement surgery (THR 65), with arrow pointing to cancellous bone tissue in
the proximal femur. (B) Cancellous bone tissue fragments isolated from three different femoral head surgical specimens (THRs 63, 65,
and 76) revealing variation in yellow versus red marrow content. (C) Histologic section of cancellous bone tissue fragment stained with
hematoxylin and eosin reveals abundant adipocyte “ghosts” (red arrow) within the marrow compartment next to a mineralized bone
spicule (white arrow). (D) Fluorescence image of a cancellous bone tissue spicule labeled with Osteosense 680 (red arrow) and
surrounded by adipocytes (white arrow). (E) Fat micelles released into the medium of a cultured bone tissue fragment (white arrow). (F)
Adipocytes isolated from bone fragment marrow growing in culture.
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0.5252. The viability of breast cancer cells within colonized fragments
following migration was previously demonstrated by culturing the
flushed marrows from BLI-positive fragments to demonstrate the
subsequent outgrowth of MDA-MB-231-fLuc-EGFP cells [30]. Breast
cancer cell colonization of one or more bone tissue fragments from 11/
14 of the THR specimens was observed, as shown in Figure 3D. These
results demonstrate osteotropic behavior of MDA-MB-231-
fLuc-EGFP breast cancer cells for human bone tissue fragments.
Breast Cancer Cell Line Migration to Bone
Culture Supernatants
Comparison of migration patterns through microporous mem-
branes revealed that MDA-MB-231-fLuc-EGFP cells, but not
MCF-7-fLuc-EGFP, SKBR3-fLuc-EGFP, and MCF10A-fLuc-
EGFP breast cancer cells, exhibited significantly greater migration
toward bone tissue-conditioned medium versus control medium as
shown in Figure 4D (P b .01). These patterns are consistent with
other in vitro and in vivo studies demonstrating highly robust
migration and metastatic behavior of MDA-MB-231-fLuc-EGFP
cells relative to other breast cancer cell lines [12,38]. Thus, althoughER-positive breast cancer cells effectively colonize the skeleton and are
responsible for most late breast cancer recurrence, MDA-MB-231-
fLuc-EFGP cells were used for subsequent migration assays in this
study. Quantitative BLI analysis of MDA-MB-231-fLuc-EFGP
migration to bone culture supernatants generated from 14 hip
replacement specimens demonstrated that MDA-MB-231-fLuc-
EFGP migration was greater toward bone-conditioned medium
versus control medium in 12/14 specimens (P = .0014), as illustrated
in Figure 5A, but varied across specimens. Fold increase in BLI signal
associated with migration to conditioned versus control medium
ranged from 0.75 to 3.5× (Figure 5B) across the 14 THR specimens
analyzed. These results demonstrate that MDA-MB-231-fLuc-EFGP
cell migration was consistently greater to bone-conditioned medium
relative to control medium and that the magnitude of this increase
varied across the 14 specimens.
Breast Cancer Cell Migration as a Function of Bone
Tissue Secretome
To determine if levels of secreted factors present in bone-
conditioned medium were associated with MDA-MB-231-fLuc-
EGFP migration patterns, we used linear mixed model regression
A B
20X 20X
C D
45 µm65 µm
40X
Figure 2. Breast cancer cells establish direct contact with adipocytes during colonization of the bone marrow compartment when
co-cultured with cancellous human bone tissue fragments. (A) Fluorescence image of a cancellous bone tissue fragment seeded with
MCF-7-fLuc-EGFP cells (green arrow) shown in direct contact with adipocytes (white arrow) at 24 hours. (B) Post co-culture
immunohistochemical staining with AE1/3 anti-cytokeratin antibody detecting MCF-7-fLuc-EFGP cell colonization (green arrow) adjacent
to adipocytes (white arrow). (C) Confocal microscopy of co-cultures at 48 hours following staining with Oil Red to define adipocytes (white
arrow) and Osteosense 680 to define bone spicules (red arrow). A video of the image in panel (C) is provided in Supplementary Data Video
1. (D) MCF-7-fLuc-EGFP cells (green arrow) are shown in direct contact with adipocyte (white arrow).
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on triplicate supernatant samples from 13 THR specimens to
analyze migration as a function of all 75 analytes measured in our
multiplex immunoassay (Supplementary Data Table 1). After
controlling for age, gender, and FDR, increasing levels of 16 factors
were significantly associated (P b .05) with MDA-MB-231-fLuc-
EFGP migration: leptin, IL-1β, IL-1α, MCP-3, TNFα, IL-17A,
TGFα, MIP-1β, IL-13, IL-10, GM-CSF, fractalkine, CD40L,
TRAIL, IL-20, and I-309. Decreasing levels of three factors were
significantly associated with migration: SOST, ACTH, and
RANKL. These results confirm previously published findings
suggesting that a broad constellation of secreted factors from many
bone cell types participates in the recruitment of breast cancer cells
into the bone microenvironment.
Because of the limited sample size of 13 THR specimens and
collinearity issues associated with analyzing high numbers of analytes
from multiple multiplex panels, we were not able to perform
multivariate regression analysis on all 75 analytes. Thus, multivariate
regression analysis was performed on a limited group of analytes of
interest interrogated by a single immunoassay kit panel. Given the
high level of adiposity observed in the bone fragments and the
observed infiltration of breast cancer cells into the bone marrow
adipose compartment over the course of our studies, we wereparticularly interested in the role of the adipokine leptin. In addition,
a recent report identifying MDA-MB-231 breast cancer cell
expression of IL-1β as a determinant of bone homing in a mouse
model [39] led us to focus our attention on this analyte, which is also
secreted by adipocytes. As such, we performed our multivariate
regression analysis of migration patterns on a subset of adipokines and
cytokines interrogated by the MILLIPLEX MAP Human Bone Panel
magnetic bead immunoassay kit: leptin, IL-1β, and three other
bone-secreted factors previously implicated in breast cell osteotropism
(IL-6, OPG, and OPN) [9,12]. Of these factors, increasing levels of
leptin and IL-1β were significantly associated with migration (before
and after adjustment for age and gender) in both univariate regression
(P b .0001) and multivariate regression analysis (P = .006 and P =
.001, respectively). Scatter plots displaying migration patterns as a
function of increasing levels of each factor are shown in Figure 6A,
with regression coefficients and associated P values listed in
Figure 6B. These results reveal that increasing levels of leptin and
IL-1β in human bone tissue-conditioned medium promote breast
cancer cell migration.
Discussion
In this study, we employed a human bone tissue explant model
representing the aging skeleton, which is frequently the target of
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Figure 3. Breast cancer cells migrate through microporous membranes to human bone tissue fragments. (A) Nontraditional “reverse”
migration assay design showing MDA-MB-231-fLuc-EGFP cells seeded onto the lower surface of an insert with an 8-μm porous
membrane, through which they migrate to colonize a bone tissue fragment or a control glass bead. (B) Following colonization, fragments
and glass beads are transferred to fresh culture wells at 24 h. (C) BLI detects breast cell colonization of bone fragment but not glass bead
at 24 h. (D) Histogram showing the number of tissue fragments and glass beads with versus without bioluminescence signal.
Experiments were performed in triplicate (n = 3 fragments and 3 beads) for each of 14 THR specimens. Signal was observed in a
significantly greater number of bone tissue fragments (15/42) versus glass beads (3/42) (*P = .003).
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migration and colonization. The cancellous tissues used in this culture
system were isolated from the proximal femur region of femoral heads
discarded following hip replacement surgeries. The proximal femur is
a frequent site of breast cancer metastasis and harbors metabolically
active red marrow typically targeted by metastatic spread to the
skeleton [5,6,40]. Hip replacement procedures are most commonly
performed in individuals aged 50 to 80 years, an age range that
brackets the years of peak breast cancer incidence. In our culture
system, bone tissues are maintained as intact three-dimensional
fragments that retain both the mineralized spicules and marrow
compartment with all potentially relevant cell types. As such, these
tissues represent the microenvironment in which breast cancer metastasis
unfolds within the skeleton, providing the opportunity to discover
previously unrecognized interactions between breast cancer cells and
bone, including the bone marrow adipose tissue compartment.
A recurring observation during all aspects of our work with these
tissues has been the overwhelming presence of adipose tissue within
the “red marrow,” confirmed by histology, fluorescence microscopy,
and the copious production of fat micelles in all culture supernatants.
These observations are in keeping with the well-established
association between increasing bone marrow adipose with age,
which occupies up to 68% of the aging bone marrow compartment
(including up to 40% of the red marrow) [26,41,42]). When breast
cancer cells were seeded directly onto bone tissue fragments in
culture, they routinely migrated into the bone marrow adipose tissue,establishing direct, extended contact with adipocytes. These patterns
are consistent with the fact that the human mammary gland is
surrounded by a stroma heavily populated by adipose tissue and that
adipose tissue is instrumental in directing mammary gland
development and primary tumorigenesis [43–47]. Breast cells appear
to be exquisitely responsive to the adipose tissue microenvironment,
manifested through secreted factors, extracellular matrix components,
and cell/cell contacts [45], and studies have shown that these
interactions can lead to the emergence of cancer associated adipocytes
that promote local tumor progression via stimulation of proliferation,
invasion, and angiogenesis [48,49]. As adipose tissue appears to be
fundamentally involved in the regulation of breast cell development
and tumorigenesis within the mammary gland, it is biologically
plausible that breast cancer cells would colonize the bone marrow
adipose tissue compartment during metastatic progression. In keeping
with breast cancer colonization of the bone marrow adipose tissue, we
also observed a strong association between breast cancer cell migration
in Transwell assays with increasing levels of the adipokines/cytokines
leptin and IL-1β in bone-conditioned medium.
Leptin, an adipokine secreted primarily by adipocytes, regulates
satiety and energy balance through receptors located in the
hypothalamus. Leptin levels in the blood correlate with body mass
index and have been implicated as a link between obesity and
numerous pathologies including breast cancer [50–56]. Studies have
shown that leptin levels are higher in breast cancer patients than in
healthy women, are elevated in obese women with versus without
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Figure 4. Breast cancer cells migrate through microporous membranes to human bone tissue fragment-conditioned medium. (A)
Traditional migration assay design showing MDA-MB-231-fLuc-EGFP cells seeded onto the upper surface of an insert with an 8-μm
porous membrane, through which they migrate to into the receiver well containing bone tissue fragment culture supernatant. (B)
Postmigration attachment of cells to the bottom of the well. (C) BLI of the receiver plate after removal of the insert following a 20-hour
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from THR specimen 61 reveals enhanced migration of MDA-MB-231-fLuc-EGFP cells to bone tissue supernatant versus control medium
(*P b .01), whereas enhanced migration was not observed for the other three breast cell lines: SKBR3-fLuc-EGFP, MCF-10A-fLuc-EGFP,
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[52,53,56,57]. In addition, leptin receptors are expressed by breast
tumors and correlate with tumor size and poor prognosis in patients with
high leptin levels [51,58–60]. In animal models, mammary tumor
development is reduced in obese, leptin-deficient versus leptin-intactmice
[61]. Numerous in vitro studies have shown that leptin promotes the
proliferation, migration, and survival of breast cancer cell lines through
leptin receptor–activated signaling pathways, including those that regulate
the stem cell phenotype and the EMT process [51,62–70].
IL-1β, a pleiotropic cytokine/adipokine produced by a variety of
cell types including macrophages, malignant cells, and adipocytes, is
widely associated with tumorigenesis and metastatic progression in
animal models and is overexpressed in human metastatic tumor
tissues [71]. Its secretion by malignant cells and/or the tumor
microenvironment has been proposed to fuel tumor-associated
inflammation to promote tumor invasiveness through paracrine and
autocrine mechanisms [72]. A role in breast cancer cell osteotropism
has recently been identified in a mouse model of metastasis where
elevated breast cancer cell expression of IL-1β was responsible for
MDA-MB-231 breast cancer cell homing to bone [39]. Extension ofthis study to the analysis of tumor tissues from Stage II/III breast
cancer patients demonstrated that patients with IL-1β–positive
primary tumors were more likely to develop bone metastases than
patients with IL-1β–negative tumors. Although these studies
implicate an autocrine mechanism in which breast tumor cell
expression drives bone-seeking behavior, our experiments suggest that
IL-1β derived from the bone tissue microenvironment also fuels
osteotropic breast cancer cell behavior.
As our migration experiments were performed using intact tissues,
we did not determine the cellular origin of leptin or IL-1β in
bone-conditioned medium. Leptin is secreted primarily by adipose
tissues [73,74], and others have reported leptin secretion by isolated
bone marrow adipocytes in culture [75]. However, leptin is also
secreted in low amounts by other bone cells, including osteoblasts
[76,77]. Osteoblasts and adipocytes both originate from mesenchy-
mal stem cells and share some common markers [76]. Although leptin
expression by osteoblasts has been reported during the late maturation
phase [77], given the size and numbers of adipocytes within the aging
bone marrow niche, it is likely that they constitute the predominant
source of leptin in the bone-conditioned medium used in our studies.
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increase in migration in the presence of bone-conditioned medium, determined as the ratio of average triplicate BLI signal for migration to
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also recognized as an adipokine, and its secretion has been detected in
conditioned medium of cultured human preadipocytes, adipocytes,
and explanted subcutaneous abdominal adipose tissues [78].
Our observations that breast cancer cells are recruited to human bone
tissue-conditioned medium by leptin and IL-1β and colonize the bone
marrow adipose tissue compartment of cultured bone tissue fragments
are in keeping with an emerging body of work by others demonstrating
a seminal role for adipose tissue in fueling ovarian and prostate cancer
metastasis [17,28,79,80]. Most ovarian cancers preferentially metasta-
size to the omentum, an apron-like fold of visceral peritoneum
populated by fat cells that extends from the stomach over the lower
intestines. Nieman et al. demonstrated that adipocytes promote ovarian
cancer cell homing, migration, and invasion of the omentum through
the secretion of IL-8, IL-6, MCP-1, and TIMP [79,80]. This work also
revealed that during metastatic progression within the omentum,
ovarian cancer cells exhibit upregulation of the fatty acid chaperone
molecule FABP4, which mediates lipid trafficking and the transfer and
uptake of free fatty acids from adipocytes that fuel cancer cell growth.
Adipose tissue also appears to be centrally involved in the progression of
prostate cancer, which preferentially metastasizes to bone [28]. Using a
high-fat diet to induce bone marrow adiposity in a mouse modelcoupled with in vitro studies, Herroon et al. demonstrated that prostate
tumors grow faster in a high-fat environment; that lipids are transferred
from adipocytes to tumor cells; and that marrow adipocytes fuel the
growth and invasiveness of prostate cancer cells by stimulating the
upregulation of IL-1β, HMOX-1, and FABP4 [17]. Extending their in
vitro work to breast cancer cells, this group also reported that
MDA-MB-231-BO cells exhibited increased growth and invasiveness
in the presence of adipocyte-conditioned medium. Using the same
model, Hardaway et al. have demonstrated the role of bone marrow
adipose-derived CXCL1 and CXCL2 cytokines in driving the osteolytic
process during prostate cancer progression in the skeleton, showing in
in vitro studies that adipocyte-driven osteoclastogenesis could be
reversed through CXCL1 and CXCL2 neutralization. [81]. Their
findings are supported by clinical associations implicating an
inflammation-driven promotion of progression within the bone that
activates the osteolytic cycle. Together, these previously published
studies reveal that cancer cells can exploit adipose tissue to thrive during
metastasis, providing solid mechanistic evidence that some adipose
tissues drive colonization, growth, invasion, and osteolytic processes
[17,28,79–81].
A potential role for marrow adipose tissue in breast cancer
metastatic progression to bone is also consistent with the established
AB
Figure 6. MDA-MB-231-fLuc-EGFP breast cancer cell migration is associated with specific factors present in bone tissue-conditioned
medium. (A) Scatter plots illustrating breast cancer cell migration as a function of leptin, IL-1β, OPG, OPN, and IL-6 levels in
bone-conditioned medium generated by 13 THR specimens. Triplicate sets of bone-conditioned and control medium for each of the 13
THR specimens were used for migrations assays andMILLIPLEX analysis. Migration, detected by BLI, is plotted on the Y-axis, and analyte
concentration, expressed as MFI, is plotted on the X-axis. (B) Regression analysis of MDA-MB-231-fLuc-EGFP cell migration as a function
of analyte levels. Coefficients and P values generated by univariate regression analysis (before and after adjustment for age and gender)
and multivariate regression analysis (age and gender included as covariates). Breast cancer cell migration was significantly associated
with increasing levels of leptin and IL-1β.
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One explanation for this association is that local and/or circulating
levels of adipokines and cytokines, including leptin, IL-1β, TNF-a,
MCP-1, IL6, and IL8, fuel the progression of breast cancer
[50,83–86]. This constellation of factors is upregulated during
obesity and the associated state of chronic inflammation during which
subcutaneous and visceral adipose tissues become heavily infiltrated
with immune cells, including macrophages that produce a variety of
inflammatory cytokines [83]. However, a recent study did not find a
relationship between circulating inflammatory adipokines and breast
cancer risk, leading to the suggestion that serum levels of these factors,
which tend to signal through paracrine interactions, may not
constitute the appropriate surrogate measurement [87]. Our analysis
of the human bone secretome suggests that many of these factors are
produced in the bone and may signal to breast cancer cells arriving in the
bone marrow vasculature to infiltrate and colonize the marrow adipose
tissue. Thus, it is possible that cross talk and direct interactions between
breast cancer cells and adipose tissue within the microenvironment of thebone may also underlie the association between adipose-associated factors
and poor breast cancer outcomes. Future analysis of these mechanisms
may therefore lead to improved therapeutic strategies for themanagement
of breast cancer metastasis to bone.
Conclusions
Our findings in a human bone tissue explant model reveal that breast
cancer cells colonize the bone marrow adipose niche and suggest that
they are recruited to human bone tissue by leptin and IL-1β. Bone
marrow adipose tissue and its molecular signals may be important but
understudied components of the breast cancer metastatic niche.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2015.11.005.
Contributions
B. L. K. conceived the study. B. L. K., W.-R. L., C.H.C., and Z. S. T.
designed experiments. Z. S. T., R. A.,M.H. B., and B. L. K. performed
experiments. W.-R. L. performed multiplex immunoassay analysis. K. L.
Neoplasia Vol. 17, No. 12, 2015 Breast Cancer Cell Colonization of Bone Templeton et al. 859and B. L. K. performed confocal fluorescencemicroscopy. J. T. andW.W.
performed statistical analyses. W. J. M. provided surgical bone tissue
specimens. B. L. K., W.-R. L., and W. W. wrote the manuscript.
Acknowledgements
These studies were funded, in part, by grants from the Alternative
Research and Development Foundation (107588), the National
Institutes of Health (5R01CA172895-02), and the California Breast
Cancer Research Program (201B-0141) and generous support from
the Chambers Family Foundation. This work was also supported, in
part, by the National Institutes of Health (P30CA124435) using the
following Stanford Cancer Institute Shared Resources: Human
Immune Monitoring Shared Resource, Cell Sciences Imaging Shared
Resource, and Biostatistics and Research Bioinformatics Shared
Resource. We thank Drs. Andrew Wilber and R. Scott McIvor for
the generous donation of their bpKT2/LuBiGN transposon and pK/
hUbiC-SB11 transposase plasmids. We gratefully acknowledge
Nancy Bellagamba for facilitating the collection of THR specimens.
Literature Cited
[1] Coleman RE and Rubens RD (1987). The clinical course of bone metastases
from breast cancer. Br J Cancer 55(1), 61–66 [Epub 1987/01/01. PubMed
PMID: 3814476].
[2] Mundy GR (2002). Metastasis to bone: causes, consequences and therapeutic
opportunities.Nat Rev Cancer 2(8), 584–593. http://dx.doi.org/10.1038/nrc867
[Epub 2002/08/03, PubMed PMID: 12154351].
[3] Paget S (1989). The distribution of secondary growths in cancer of the breast.
Cancer Metastasis Rev 8(2), 98–101 [PubMed PMID: 2673568].
[4] Fidler IJ (2003). The pathogenesis of cancer metastasis: the 'seed and soil'
hypothesis revisited. Nat Rev Cancer 3(6), 453–458. http://dx.doi.org/10.1038/
nrc1098 [PubMed PMID: 12778135].
[5] Mastro AM, Gay CV, and Welch DR (2003). The skeleton as a unique
environment for breast cancer cells. Clin Exp Metastasis 20(3), 275–284
[PubMed PMID: 12741685].
[6] Yoneda T (1997). Arterial microvascularization and breast cancer colonization in
bone. Histol Histopathol 12(4), 1145–1149 [PubMed PMID: 9302573].
[7] Bersini S, Jeon JS, Dubini G, Arrigoni C, Chung S, Charest JL, Moretti M, and
Kamm RD (2014). A microfluidic 3D in vitro model for specificity of breast
cancer metastasis to bone. Biomaterials 35(8), 2454–2461. http://dx.doi.org/10.
1016/j.biomaterials.2013.11.050 [Epub 2014/01/07, PubMed PMID:
24388382; PMCID: 3905838].
[8] Bussard KM, Venzon DJ, andMastro AM (2010). Osteoblasts are a major source
of inflammatory cytokines in the tumor microenvironment of bone metastatic
breast cancer. J Cell Biochem 111(5), 1138–1148. http://dx.doi.org/10.1002/jcb.
22799 [Epub 2010/08/05, PubMed PMID: 20683902].
[9] Chen X, Lu J, Ji Y, Hong A, and Xie Q (2014). Cytokines in osteoblast-condi-
tioned medium promote the migration of breast cancer cells. Tumour Biol 35(1),
791–798. http://dx.doi.org/10.1007/s13277-013-1109-0 [PubMed PMID:
24026883].
[10] Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I,
Morony S, Rubin E, Sarao R, and Hojilla CV, et al (2006). Regulation of cancer
cell migration and bone metastasis by RANKL. Nature 440(7084), 692–696.
http://dx.doi.org/10.1038/nature04524 [PubMed PMID: 16572175].
[11] Kapoor P, Suva LJ, Welch DR, and Donahue HJ (2008). Osteoprotegrin and the
bone homing and colonization potential of breast cancer cells. J Cell Biochem
103(1), 30–41. http://dx.doi.org/10.1002/jcb.21382 [PubMed PMID:
17471510].
[12] Koro K, Parkin S, Pohorelic B, Yang AD, Narendran A, Egan C, and Magliocco A
(2011). Interactions between breast cancer cells and bone marrow derived cells in
vitro define a role for osteopontin in affecting breast cancer cell migration. Breast
Cancer Res Treat 126(1), 73–83. http://dx.doi.org/10.1007/s10549-010-0889-9
[Epub 2010/04/20, PubMed PMID: 20401631].
[13] Martinez LM, Vallone VB, Labovsky V, Choi H, Hofer EL, Feldman L,
Bordenave RH, Batagelj E, Dimase F, and Villafane AR, et al (2014). Changes in
the peripheral blood and bone marrow from untreated advanced breast cancerpatients that are associated with the establishment of bone metastases. Clin Exp
Metastasis 31(2), 213–232. http://dx.doi.org/10.1007/s10585-013-9622-5
[PubMed PMID: 24173696].
[14] Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T,
Murphy E, Yuan W, and Wagner SN, et al (2001). Involvement of chemokine
receptors in breast cancer metastasis. Nature 410(6824), 50–56. http:
//dx.doi.org/10.1038/35065016 [PubMed PMID: 11242036].
[15] Pohorelic B, Singh R, Parkin S, Koro K, Yang AD, Egan C, and Magliocco A
(2012). Role of Src in breast cancer cell migration and invasion in a breast
cell/bone-derived cell microenvironment. Breast Cancer Res Treat 133(1),
201–214. http://dx.doi.org/10.1007/s10549-011-1753-2 [Epub 2011/09/07,
PubMed PMID: 21894461].
[16] Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y, and Qu X
(2012). C-Src-mediated RANKL-induced breast cancer cell migration by
activation of the ERK and Akt pathway. Oncol lett 3(2), 395–400. http:
//dx.doi.org/10.3892/ol.2011.487 [PubMed PMID: 22740919; PMCID:
3362513].
[17] Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A,
Feldmann D, and Podgorski I (2013). Bone marrow adipocytes promote tumor
growth in bone via FABP4-dependent mechanisms. Oncotarget 4(11),
2108–2123 [PubMed PMID: 24240026; PMCID: 3875773].
[18] Shiozawa Y, Eber MR, Berry JE, and Taichman RS (2015). Bone marrow as a
metastatic niche for disseminated tumor cells from solid tumors. BoneKEy rep 4,
689. http://dx.doi.org/10.1038/bonekey.2015.57 [PubMed PMID: 26029360;
PMCID: 4440229].
[19] Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J, Kim JK,
Patel LR, Ying C, and Ziegler AM, et al (2011). Human prostate cancer
metastases target the hematopoietic stem cell niche to establish footholds in
mouse bone marrow. J Clin Invest 121(4), 1298–1312. http://dx.doi.org/10.
1172/JCI43414 [PubMed PMID: 21436587; PMCID: 3069764].
[20] Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D,
Koller A, Hajjar KA, and Stainier DY, et al (2013). The perivascular niche
regulates breast tumour dormancy. Nat Cell Biol 15(7), 807–817. http:
//dx.doi.org/10.1038/ncb2767 PubMed PMID: 23728425; PMCID: 3826912.
[21] Wang H, Yu C, Gao X, Welte T, Muscarella AM, Tian L, Zhao H, Zhao Z, Du
S, and Tao J, et al (2015). The osteogenic niche promotes early-stage bone
colonization of disseminated breast cancer cells. Cancer cell 27(2), 193–210. http:
//dx.doi.org/10.1016/j.ccell.2014.11.017 [PubMed PMID: 25600338;
PMCID: 4326554].
[22] Bissell MJ and Radisky D (2001). Putting tumours in context. Nat Rev Cancer
1(1), 46–54. http://dx.doi.org/10.1038/35094059 [Epub 2002/03/20, PubMed
PMID: 11900251; PMCID: 2975572].
[23] Joyce JA and Pollard JW (2009). Microenvironmental regulation of metastasis.
Nat Rev Cancer 9(4), 239–252. http://dx.doi.org/10.1038/nrc2618 [Epub
2009/03/13, PubMed PMID: 19279573; PMCID: 3251309].
[24] Place AE, Jin Huh S, and Polyak K (2011). The microenvironment in breast
cancer progression: biology and implications for treatment. Breast Cancer Res
13(6), 227. http://dx.doi.org/10.1186/bcr2912 [Epub 2011/11/15, PubMed
PMID: 22078026; PMCID: 3326543].
[25] Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen
CJ, and Klibanski A (2013). Marrow fat and bone–new perspectives. J Clin
Endocrinol Metab 98(3), 935–945. http://dx.doi.org/10.1210/jc.2012-3634
[PubMed PMID: 23393168; PMCID: 3590487].
[26] Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, and Kassem M
(2001). Adipocyte tissue volume in bone marrow is increased with aging and in
patients with osteoporosis. Biogerontology 2(3), 165–171 [PubMed PMID:
11708718].
[27] Scheller EL and Rosen CJ (2014). What's the matter with MAT? Marrow
adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci 1311, 14–30.
http://dx.doi.org/10.1111/nyas.12327 [PubMed PMID: 24650218; PMCID:
4049420].
[28] Hardaway AL, Herroon MK, Rajagurubandara E, and Podgorski I (2014). Bone
marrow fat: linking adipocyte-induced inflammation with skeletal metastases.
Cancer Metastasis Rev 33(2–3), 527–543. http://dx.doi.org/10.1007/s10555-013-
9484-y [Epub 2014/01/09, PubMed PMID: 24398857; PMCID: 4154371].
[29] Contag CH, Lie WR, Bammer MC, Hardy JW, Schmidt TL, Maloney WJ, and
King BL (2014). Monitoring dynamic interactions between breast cancer cells
and human bone tissue in a co-culture model.Mol Imaging Biol 16(2), 158–166.
http://dx.doi.org/10.1007/s11307-013-0685-0 [Epub 2013/09/07, PubMed
PMID: 24008275].
860 Breast Cancer Cell Colonization of Bone Templeton et al. Neoplasia Vol. 17, No. 12, 2015[30] Templeton ZS, Bachmann MH, Alluri RV, Maloney WJ, Contag CH, and King
BL (2015). Methods for Culturing Human Femur Tissue Explants to Study
Breast Cancer Cell Colonization of the Metastatic Niche. J Vis Exp 97(e52656),
1–10. http://dx.doi.org/10.3791/52656.
[31] Multhaup M, Karlen AD, Swanson DL, Wilber A, Somia NV, Cowan MJ, and
McIvor RS (2010). Cytotoxicity associated with artemis overexpression after
lentiviral vector-mediated gene transfer. Hum Gene Ther 21(7), 865–875. http:
//dx.doi.org/10.1089/hum.2009.162 [Epub 2010/02/19, 162. PubMed PMID:
20163250; PMCID: 2938362].
[32] Thorne SH, Barak Y, Liang W, Bachmann MH, Rao J, Contag CH, and Matin
A (2009). CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy. Mol
Cancer Ther 8(2), 333–341 [Epub 2009/02/05. doi: 1535–7163.
MCT-08-0707 [pii] 10.1158/1535-7163.MCT-08-0707. PubMed PMID:
19190118].
[33] Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA,
Nealon C, Dakic A, and Simic V, et al (2012). ROCK inhibitor and feeder cells
induce the conditional reprogramming of epithelial cells. Am J Pathol 180(2),
599–607. http://dx.doi.org/10.1016/j.ajpath.2011.10.036 [Epub 2011/12/23,
PubMed PMID: 22189618; PMCID: 3349876].
[34] Rosenberg-Hasson Y, Hansmann L, Liedtke M, Herschmann I, and Maecker
HT (2014). Effects of serum and plasma matrices on multiplex immunoassays.
Immunol Res 58(2–3), 224–233. http://dx.doi.org/10.1007/s12026-014-8491-6
[PubMed PMID: 24522699; PMCID: 4332596].
[35] Johansson JU, Pradhan S, Lokteva LA, Woodling NS, Ko N, Brown HD, Wang
Q, Loh C, Cekanaviciute E, and Buckwalter M, et al (2013). Suppression of
inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in
macrophages and brain microglia. J Neurosci 33(40), 16016–16032. http:
//dx.doi.org/10.1523/JNEUROSCI.2203-13.2013 [PubMed PMID:
24089506; PMCID: 3787507].
[36] Team RC (2012). R: A language and environment for statistical computing.
Foundation for Statistical Computing.
[37] Bates DM, Maechler M, and Bolker B (2012). lmme4: Linear mixed-effects
models using S4 classes. R package version 0.999999-0.
[38] Kim IS and Baek SH (2010). Mouse models for breast cancer metastasis. Biochem
Biophys Res Commun 394(3), 443–447. http://dx.doi.org/10.1016/j.bbrc.2010.
03.070 [Epub 2010/03/17, PubMed PMID: 20230796].
[39] Nutter F, Holen I, Brown HK, Cross SS, Evans CA, Walker M, Coleman RE,
Westbrook JA, Selby PJ, and Brown JE, et al (2014). Different molecular profiles
are associated with breast cancer cell homing compared with colonisation of
bone: evidence using a novel bone-seeking cell line. Endocr Relat Cancer 21(2),
327–341. http://dx.doi.org/10.1530/ERC-13-0158 [PubMed PMID:
24413608].
[40] Riccio AI, Wodajo FM, and Malawer M (2007). Metastatic carcinoma of the
long bones. Am Fam Physician 76(10), 1489–1494 [Epub 2007/12/07, PubMed
PMID: 18052014].
[41] Vande Berg BC, Malghem J, Lecouvet FE, and Maldague B (1998). Magnetic
resonance imaging of normal bone marrow. Eur Radiol 8(8), 1327–1334. http:
//dx.doi.org/10.1007/s003300050547 [PubMed PMID: 9853209].
[42] Hwang S and Panicek DM (2007). Magnetic resonance imaging of bone marrow
in oncology, Part 1. Skeletal Radiol 36(10), 913–920. http://dx.doi.org/10.1007/
s00256-007-0309-3 [PubMed PMID: 17492443].
[43] Wiseman BS and Werb Z (2002). Stromal effects on mammary gland
development and breast cancer. Science 296(5570), 1046–1049. http:
//dx.doi.org/10.1126/science.1067431 [PubMed PMID: 12004111; PMCID:
2788989].
[44] Gnerlich JL, Yao KA, Fitchev PS, Goldschmidt RA, BondMC, Cornwell M, and
Crawford SE (2013). Peritumoral expression of adipokines and fatty acids
in breast cancer. Ann Surg Oncol 20(Suppl 3), S731–S738. http:
//dx.doi.org/10.1245/s10434-013-3274-1 [PubMed PMID: 24052317].
[45] Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C,
Flanagan L, Tenniswood MP, Guha C, and Lisanti MP, et al (2003). Adipocyte-
secreted factors synergistically promote mammary tumorigenesis through
induction of anti-apoptotic transcriptional programs and proto-oncogene
stabilization. Oncogene 22(41), 6408–6423. http://dx.doi.org/10.1038/sj.onc.
1206737 [PubMed PMID: 14508521].
[46] Liu E, Samad F, and Mueller BM (2013). Local adipocytes enable
estrogen-dependent breast cancer growth: Role of leptin and aromatase.
Adipocyte 2(3), 165–169. http://dx.doi.org/10.4161/adip.23645 [PubMed
PMID: 23991363; PMCID: 3756105].[47] Landskroner-Eiger S, Park J, Israel D, Pollard JW, and Scherer PE (2010).
Morphogenesis of the developing mammary gland: stage-dependent impact of
adipocytes. Dev Biol 344(2), 968–978. http://dx.doi.org/10.1016/j.ydbio.2010.
06.019 [PubMed PMID: 20599899; PMCID: 2917626].
[48] Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY,
Meulle A, Salles B, and Le Gonidec S, et al (2011). Cancer-associated adipocytes
exhibit an activated phenotype and contribute to breast cancer invasion. Cancer
Res 71(7), 2455–2465. http://dx.doi.org/10.1158/0008-5472.CAN-10-3323
[PubMed PMID: 21459803].
[49] Park J, Morley TS, Kim M, Clegg DJ, and Scherer PE (2014). Obesity and
cancer–mechanisms underlying tumour progression and recurrence. Nat Rev
Endocrinol 10(8), 455–465. http://dx.doi.org/10.1038/nrendo.2014.94
[PubMed PMID: 24935119; PMCID: 4374431].
[50] Khan S, Shukla S, Sinha S, and Meeran SM (2013). Role of adipokines and
cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine
Growth Factor Rev 24(6), 503–513. http://dx.doi.org/10.1016/j.cy-
togfr.2013.10.001 [PubMed PMID: 24210902].
[51] Garcia-Robles MJ, Segura-Ortega JE, and Fafutis-Morris M (2013). The biology
of leptin and its implications in breast cancer: a general view. J Interferon Cytokine
Res 33(12), 717–727. http://dx.doi.org/10.1089/jir.2012.0168 [Epub
2013/07/23, PubMed PMID: 23869900].
[52] Niu J, Jiang L, Guo W, Shao L, Liu Y, and Wang L (2013). The Association
between Leptin Level and Breast Cancer: A Meta-Analysis. PloS one 8(6),
e67349. http://dx.doi.org/10.1371/journal.pone.0067349 [PubMed PMID:
23826274; PMCID: 3694967].
[53] Saxena NK and Sharma D (2013). Multifaceted leptin network: the molecular
connection between obesity and breast cancer. J Mammary Gland Biol Neoplasia
18(3–4), 309–320. http://dx.doi.org/10.1007/s10911-013-9308-2 [PubMed
PMID: 24214584].
[54] Schmidt S, Monk JM, Robinson LE, and Mourtzakis M (2015). The integrative
role of leptin, oestrogen and the insulin family in obesity-associated breast cancer:
potential effects of exercise. Obes Rev 16(6), 473–487. http://dx.doi.org/10.
1111/obr.12281 [PubMed PMID: 25875578].
[55] Ando S, Barone I, Giordano C, Bonofiglio D, and Catalano S (2014). The
Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment
in Driving Breast Cancer Growth and Progression. Front oncol 4, 340. http:
//dx.doi.org/10.3389/fonc.2014.00340 [PubMed PMID: 25505738; PMCID:
4245002].
[56] Romero-Figueroa Mdel S, Garduno-Garcia Jde J, Duarte-Mote J,
Matute-Gonzalez G, Gomez-Villanueva A, and De la Cruz-Vargas J (2013).
Insulin and leptin levels in obese patients with and without breast cancer. Clin
Breast Cancer 13(6), 482–485. http://dx.doi.org/10.1016/j.clbc.2013.08.001
[Epub 2013/10/03, PubMed PMID: 24084031].
[57] Delort L, Rossary A, Farges MC, Vasson MP, and Caldefie-Chezet F (2015).
Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor
immunity. Life Sci 140, 37–48. http://dx.doi.org/10.1016/j.lfs.2015.04.012
[PubMed PMID: 25957709].
[58] Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J,
Russo A, Sulkowski S, and Surmacz E (2006). Increased expression of leptin and the
leptin receptor as a marker of breast cancer progression: possible role of obesity-related
stimuli. Clin Cancer Res 12(5), 1447–1453. http://dx.doi.org/10.1158/1078-0432.
CCR-05-1913 [Epub 2006/03/15, PubMed PMID: 16533767].
[59] Ishikawa M, Kitayama J, and Nagawa H (2004). Enhanced expression of leptin
and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10(13),
4325–4331. http://dx.doi.org/10.1158/1078-0432.CCR-03-0749 [PubMed
PMID: 15240518].
[60] Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, and
Noguchi S (2006). High expression of leptin receptor mRNA in breast cancer
tissue predicts poor prognosis for patients with high, but not low, serum leptin
levels. Int J Cancer 118(6), 1414–1419. http://dx.doi.org/10.1002/ijc.21543
[PubMed PMID: 16206269].
[61] Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA,
and Reizes O (2011). Leptin deficiency suppresses MMTV-Wnt-1 mammary
tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr
Relat Cancer 18(4), 491–503. http://dx.doi.org/10.1530/ERC-11-0102 [Epub
2011/06/04, PubMed PMID: 21636700; PMCID: 3197719].
[62] Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery
R, and Giudicelli Y (2002). Leptin mediates a proliferative response in human
MCF7 breast cancer cells. Biochem Biophys Res Commun 293(1), 622–628. http:
Neoplasia Vol. 17, No. 12, 2015 Breast Cancer Cell Colonization of Bone Templeton et al. 861//dx.doi.org/10.1016/S0006-291X(02)00205-X [Epub 2002/06/11, PubMed
PMID: 12054648].
[63] Fusco R, Galgani M, Procaccini C, Franco R, Pirozzi G, Fucci L, Laccetti P, and
Matarese G (2010). Cellular and molecular crosstalk between leptin receptor and
estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic
setting. Endocr Relat Cancer 17(2), 373–382. http://dx.doi.org/10.1677/ERC-
09-0340 [Epub 2010/04/23, PubMed PMID:20410173].
[64] Ray A, Nkhata KJ, and Cleary MP (2007). Effects of leptin on human breast
cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol
30(6), 1499–1509 [Epub 2007/05/10, PubMed PMID:17487372].
[65] Yuan HJ, Sun KW, and Yu K (2014). Leptin promotes the proliferation and
migration of human breast cancer through the extracellular-signal regulated
kinase pathway. Mol Med Rep 9(1), 350–354. http://dx.doi.org/10.3892/mmr.
2013.1786 [Epub 2013/11/12, PubMed PMID: 24213635].
[66] Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C,
Bowles AC, Dutreil MF, and Zhang S, et al (2015). Leptin produced by obese
adipose stromal/stem cells enhances proliferation and metastasis of estrogen
receptor positive breast cancers. Breast Cancer Res 17, 112. http://dx.doi.org/10.
1186/s13058-015-0622-z [PubMed PMID: 26286584; PMCID: 4541745].
[67] Dubois V, Jarde T, Delort L, Billard H, Bernard-Gallon D, Berger E, Geloen A,
Vasson MP, and Caldefie-Chezet F (2014). Leptin induces a proliferative
response in breast cancer cells but not in normal breast cells. Nutr Cancer 66(4),
645–655. http://dx.doi.org/10.1080/01635581.2014.894104 [Epub
2014/04/18, PubMed PMID: 24738610].
[68] Kim SH, Nagalingam A, Saxena NK, Singh SV, and Sharma D (2011). Benzyl
isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells
by suppressing activation of signal transducer and activator of transcription 3.
Carcinogenesis 32(3), 359–367. http://dx.doi.org/10.1093/carcin/bgq267
[PubMed PMID: 21163886; PMCID: 3105585].
[69] Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, Dang W, Tang H, Huang Y,
and Wei L, et al (2015). Activation of IL-8 via PI3K/Akt-dependent pathway is
involved in leptin-mediated epithelial-mesenchymal transition in human breast
cancer cells. Cancer Biol Ther 16(8), 1220–1230. http://dx.doi.org/10.1080/
15384047.2015.1056409 [PubMed PMID: 26121010].
[70] Wolfson B, Eades G, and Zhou Q (2015). Adipocyte activation of cancer stem
cell signaling in breast cancer. World J Biol Chem 6(2), 39–47. http:
//dx.doi.org/10.4331/wjbc.v6.i2.39 [PubMed PMID: 26009703; PMCID:
4436905].
[71] Elaraj DM,Weinreich DM, Varghese S, PuhlmannM, Hewitt SM, Carroll NM,
Feldman ED, Turner EM, and Alexander HR (2006). The role of interleukin 1
in growth and metastasis of human cancer xenografts. Clin Cancer Res 12(4),
1088–1096. http://dx.doi.org/10.1158/1078-0432.CCR-05-1603 [PubMed
PMID: 16489061].
[72] Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T,
White RM, and Gayvoronsky L, et al (2006). Effects of micro-environment- and
malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and
tumour-host interactions. Eur J Cancer 42(6), 751–759. http://dx.doi.org/10.
1016/j.ejca.2006.01.010 [PubMed PMID: 16530403].
[73] Margetic S, Gazzola C, Pegg GG, and Hill RA (2002). Leptin: a review of its
peripheral actions and interactions. Int J Obes Relat Metab Disord 26(11),
1407–1433. http://dx.doi.org/10.1038/sj.ijo.0802142 [PubMed PMID:
12439643].
[74] Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K,
Tamura N, Hosoda K, and Yoshimasa Y, et al (1995). Human obese gene
expression. Adipocyte-specific expression and regional differences in the adipose
tissue. Diabetes 44(7), 855–858 [PubMed PMID: 7789654].[75] Laharrague P, Larrouy D, Fontanilles AM, Truel N, Campfield A, Tenenbaum
R, Galitzky J, Corberand JX, Penicaud L, and Casteilla L (1998). High
expression of leptin by human bone marrow adipocytes in primary culture.
FASEB J 12(9), 747–752 [PubMed PMID: 9619453].
[76] Kollmer M, Buhrman JS, Zhang Y, and Gemeinhart RA (2013). Markers Are
Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem
Cells. J Dev Biol Tissue Eng 5(2), 18–25. http://dx.doi.org/10.5897/
JDBTE2013.0065 [PubMed PMID: 24013643; PMCID: 3765027].
[77] Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze
JO, and Drevon CA (2001). Leptin is expressed in and secreted from primary
cultures of human osteoblasts and promotes bone mineralization. J Bone Miner
Res 16(8), 1426–1433. http://dx.doi.org/10.1359/jbmr.2001.16.8.1426
[PubMed PMID: 11499865].
[78] Schipper HS, de Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA,
Prakken BJ, and Kalkhoven E (2010). A multiplex immunoassay for human
adipokine profiling. Clin Chem 56(8), 1320–1328. http://dx.doi.org/10.1373/-
clinchem.2010.146118 [PubMed PMID: 20530731].
[79] Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt
MR, Romero IL, Carey MS, Mills GB, and Hotamisligil GS, et al (2011).
Adipocytes promote ovarian cancer metastasis and provide energy for rapid
tumor growth. Nat Med 17(11), 1498–1503. http://dx.doi.org/10.1038/nm.
2492 [PubMed PMID: 22037646; PMCID: 4157349].
[80] Nieman KM, Romero IL, Van Houten B, and Lengyel E (2013). Adipose tissue
and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta
1831(10), 1533–1541. http://dx.doi.org/10.1016/j.bbalip.2013.02.010 [Epub
2013/03/19, PubMed PMID: 23500888; PMCID: 3742583].
[81] Hardaway AL, Herroon MK, Rajagurubandara E, and Podgorski I (2015).
Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in
metastatic prostate cancer. Clin Exp Metastasis 32(4), 353–368. http:
//dx.doi.org/10.1007/s10585-015-9714-5 [PubMed PMID: 25802102;
PMCID: 4393805].
[82] Ford NA, Devlin KL, Lashinger LM, and Hursting SD (2013). Deconvoluting the
obesity and breast cancer link: secretome, soil and seed interactions. J Mammary
Gland Biol Neoplasia 18(3–4), 267–275. http://dx.doi.org/10.1007/s10911-013-
9301-9 [Epub 2013/10/05, PubMed PMID: 24091864; PMCID: 3874287].
[83] Howe LR, Subbaramaiah K, Hudis CA, and Dannenberg AJ (2013). Molecular
pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin
Cancer Res 19(22), 6074–6083. http://dx.doi.org/10.1158/1078-0432 [Epub
2013/08/21, PubMed PMID: 23958744; PMCID: 3891839].
[84] Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, and Visvanathan K
(2013). Adipocytokines, inflammation, and breast cancer risk in postmenopausal
women: a prospective study. Cancer Epidemiol Biomarkers Prev 22(7),
1319–1324. http://dx.doi.org/10.1158/1055-9965.EPI-12-1444 PubMed
PMID: 23651666; PMCID: 4417498.
[85] Cho YA, Sung MK, Yeon JY, Ro J, and Kim J (2013). Prognostic role of
interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype.
Cancer Res Treat 45(3), 210–219. http://dx.doi.org/10.4143/crt.2013.45.3.210
[PubMed PMID: 24155680; PMCID: 3804733].
[86] Khandekar MJ, Cohen P, and Spiegelman BM (2011). Molecular mechanisms of
cancer development in obesity. Nat Rev Cancer 11(12), 886–895. http:
//dx.doi.org/10.1038/nrc3174 [PubMed PMID: 22113164].
[87] Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD,
Rohan TE, Manson JE, McTiernan A, and Kaplan RC, et al (2015). Circulating
Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
J Natl Cancer Inst 107(9). http://dx.doi.org/10.1093/jnci/djv169 [PubMed
PMID: 26185195].
